Avita Price Earnings Ratio from 2010 to 2024

RCEL Stock  USD 12.23  0.58  4.53%   
Avita Medical Price Earnings Ratio yearly trend continues to be quite stable with very little volatility. The value of Price Earnings Ratio is projected to decrease to -3.98. From the period between 2010 and 2024, Avita Medical, Price Earnings Ratio regression line of its data series had sample variance of  7.17 and sample variance of  7.17. View All Fundamentals
 
Price Earnings Ratio  
First Reported
2010-12-31
Previous Quarter
(3.79)
Current Value
(3.98)
Quarterly Volatility
2.67851954
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Avita Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avita Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 572.4 K or Selling General Administrative of 68.9 M, as well as many indicators such as Price To Sales Ratio of 3.57, Dividend Yield of 0.0074 or PTB Ratio of 1.13. Avita financial statements analysis is a perfect complement when working with Avita Medical Valuation or Volatility modules.
  
Check out the analysis of Avita Medical Correlation against competitors.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.

Latest Avita Medical's Price Earnings Ratio Growth Pattern

Below is the plot of the Price Earnings Ratio of Avita Medical over the last few years. It is Avita Medical's Price Earnings Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avita Medical's overall financial position and show how it may be relating to other accounts over time.
Price Earnings Ratio10 Years Trend
Very volatile
   Price Earnings Ratio   
       Timeline  

Avita Price Earnings Ratio Regression Statistics

Arithmetic Mean(5.65)
Coefficient Of Variation(47.39)
Mean Deviation2.27
Median(4.21)
Standard Deviation2.68
Sample Variance7.17
Range7.2849
R-Value0.08
Mean Square Error7.67
R-Squared0.01
Significance0.77
Slope0.05
Total Sum of Squares100.44

Avita Price Earnings Ratio History

2024 -3.98
2023 -3.79
2021 -4.21
2020 -9.91
2018 -10.18
2017 -2.89
2016 -3.58

About Avita Medical Financial Statements

Avita Medical investors utilize fundamental indicators, such as Price Earnings Ratio, to predict how Avita Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Price Earnings Ratio(3.79)(3.98)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Avita Medical is a strong investment it is important to analyze Avita Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avita Medical's future performance. For an informed investment choice regarding Avita Stock, refer to the following important reports:
Check out the analysis of Avita Medical Correlation against competitors.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.23)
Revenue Per Share
2.335
Quarterly Revenue Growth
0.432
Return On Assets
(0.45)
Return On Equity
(1.52)
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.